|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
ACT 101 Human Safety in Clinical Research
Pharmaceutical companies must pay close attention to the safety of human subjects at every stage of drug development, as explained in this QA view of the policies and regulations that make the system work.
Advertisement
Articles in this issue
about 25 years ago
Letters to the Editorabout 25 years ago
Conference Reportsabout 25 years ago
Affairs of Stateabout 25 years ago
Pen-Based Computingabout 25 years ago
Some Do--Some Watch Over Those Who Doabout 25 years ago
Communication Skills for Monitors—A Vital Training OpportunityAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Syneos Health Expands AI Ecosystem With Three New Platform Partnerships
2
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
3
When the Slack Runs Out: AI and the CRO Operating Model
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5